Tien Liang BioTech Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 10, 2022 at 06:32 pm EST
Share
Tien Liang BioTech Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 121.62 million compared to TWD 158.83 million a year ago. Net income was TWD 9.06 million compared to TWD 20.67 million a year ago. Basic earnings per share from continuing operations was TWD 0.2 compared to TWD 0.45 a year ago. Diluted earnings per share from continuing operations was TWD 0.2 compared to TWD 0.45 a year ago.
For the nine months, sales was TWD 394.74 million compared to TWD 407.88 million a year ago. Net income was TWD 44.02 million compared to TWD 20.62 million a year ago. Basic earnings per share from continuing operations was TWD 0.96 compared to TWD 0.45 a year ago. Diluted earnings per share from continuing operations was TWD 0.96 compared to TWD 0.45 a year ago.
Tien Liang BioTech Co., Ltd. is a Taiwan-based company principally engaged in the manufacture, wholesale and retail of health food products. The Company is also involved in the import, wholesale and retail of western medicines, as well as the manufacture and sales of traditional Chinese medicines. The Company also provides active pharmaceutical ingredients (APIs), biopharmaceuticals and others. The Company distributes its products in domestic market.